These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 36147518)
1. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal. Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518 [TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780 [TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. Li J; Wang Y; Zhu Y; Oupický D J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358 [TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
7. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226 [TBL] [Abstract][Full Text] [Related]
9. Chalepin: A Compound from Richardson JSM; Aminudin N; Abd Malek SN Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404 [TBL] [Abstract][Full Text] [Related]
10. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in human melanoma: past and future. Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943 [TBL] [Abstract][Full Text] [Related]
12. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice. Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944 [TBL] [Abstract][Full Text] [Related]
14. Good or not good: Role of miR-18a in cancer biology. Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of p53 regulation of oxidative stress in skeletal muscle. Beyfuss K; Hood DA Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131 [TBL] [Abstract][Full Text] [Related]
16. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. Ashraf U; Ding Z; Deng S; Ye J; Cao S; Chen Z Virulence; 2021 Dec; 12(1):968-980. PubMed ID: 33724154 [TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles for drug and gene delivery. Zhou Y; Quan G; Wu Q; Zhang X; Niu B; Wu B; Huang Y; Pan X; Wu C Acta Pharm Sin B; 2018 Mar; 8(2):165-177. PubMed ID: 29719777 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in drug delivery systems for targeting cancer stem cells. Duan H; Liu Y; Gao Z; Huang W Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Chatterton DE; Nguyen DN; Bering SB; Sangild PT Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]